• Atossa to Present at Cantor Fitzgerald Global Healthcare Conference 2023

    Источник: Nasdaq GlobeNewswire / 18 сен 2023 08:30:00   America/New_York

    SEATTLE, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative proprietary medicines to address significant unmet needs in oncology with a focus on breast cancer, today announces that the Company will take part in the upcoming Cantor Fitzgerald Global Healthcare Conference 2023.

    Details of the company's participation are as follows:

    • Cantor Fitzgerald Global Healthcare Conference 2023
    • Format: Fireside Chat with Chief Executive Officer Steven Quay, M.D., Ph.D.
    • Date and Time: Thursday, September 28th at 9:10 A.M. ET
    • Location: New York, NY

    Interested parties may access the live webcast of the fireside chat by visiting the Investors section of the Atossa website at https://investors.atossatherapeutics.com. The webcast replay will be archived on the Atossa website for 90 days following the conclusion of the event.

    About Atossa Therapeutics
    Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer. For more information, please visit www.atossatherapeutics.com.

    Contact:
    Eric Van Zanten
    VP, Investor and Public Relations
    610-529-6219
    eric.vanzanten@atossainc.com


    Primary Logo

Опубликовать